Actively Recruiting

Age: 18Years +
All Genders
NCT07165717

A Real World Study of Respiratory Critical Disease.

Led by Ming Zhong · Updated on 2025-09-10

500

Participants Needed

1

Research Sites

356 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Acute Respiratory Distress Syndrome (ARDS) is a form of acute diffuse lung injury caused by various etiologies, which rapidly progresses to acute respiratory failure. It is characterized by a sudden onset and severe clinical course. Globally, ARDS affects approximately 3 million individuals each year, accounting for about 10% of admissions to intensive care units (ICUs). Due to the lack of specific pharmacological therapies, mechanical ventilation remains the mainstay of treatment. Therefore, identifying and analyzing prognostic factors for ARDS patients is of great significance for improving patient outcomes and reducing the incidence of poor prognosis.

CONDITIONS

Official Title

A Real World Study of Respiratory Critical Disease.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with underlying diseases associated with high risk of ARDS, including but not limited to: sepsis, pneumonia, multiple trauma, pulmonary contusion, inhalation injury, massive blood transfusion, other high-risk conditions, or other factors causing excessive respiratory drive
  • Patients meeting the inclusion criteria for a high-risk ARDS population
  • Patients (or legal representatives) who have provided a signed and dated informed consent form
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • HIV infection
  • Known immunodeficiency disorders (e.g., leukemia, common variable immunodeficiency, etc.)
  • History of solid organ or bone marrow transplantation
  • Receiving treatment with G-CSF or GM-CSF
  • Patients with a decision to withdraw from active treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fudan University, Zhong Shan Hospital

Shanghai, Shanghai Municipality, China, 200032

Actively Recruiting

Loading map...

Research Team

Y

Yuxian Wang, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here